Inhibrx Biosciences, Inc.
INBX
$111.66
-$1.21-1.07%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -28.53% | -25.34% | -18.60% | -22.03% | -17.76% |
| Total Receivables | -86.35% | -13.08% | -57.86% | -25.73% | -30.28% |
| Inventory | -51.01% | -17.63% | -5.91% | -26.28% | -49.71% |
| Prepaid Expenses | 141.22% | 135.68% | 19.78% | -30.26% | -63.98% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.59% | -21.27% | 28.63% | -7.88% | -27.86% |
| Total Current Assets | -26.68% | -23.30% | -17.19% | -22.19% | -19.87% |
|
|
|||||
| Total Current Assets | -26.68% | -23.30% | -17.19% | -22.19% | -19.87% |
| Net Property, Plant & Equipment | -36.17% | -33.75% | -31.54% | 22.68% | 17.98% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -29.96% | -35.65% | -35.91% | -14.51% | 0.95% |
| Total Assets | -27.29% | -24.18% | -18.97% | -20.26% | -17.92% |
|
|
|||||
| Total Accounts Payable | -29.10% | -37.96% | -22.85% | -7.04% | -4.70% |
| Total Accrued Expenses | -31.58% | -45.20% | -17.57% | -26.43% | 3.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.85% | 22.05% | 45.83% | 22.45% | -0.09% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -27.93% | -39.25% | -17.02% | -18.40% | -0.29% |
|
|
|||||
| Total Current Liabilities | -27.93% | -39.25% | -17.02% | -18.40% | -0.29% |
| Long-Term Debt | 77.57% | 77.38% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -46.64% | -40.79% | -36.05% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 44.33% | 38.33% | 193.51% | 218.95% | 267.61% |
|
|
|||||
| Common Stock & APIC | 6.75% | 6.03% | 6.03% | 5.68% | 5.51% |
| Retained Earnings | -77.59% | -87.11% | -131.96% | -266.16% | -1,136.53% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -177.27% | -122.27% | -94.02% | -79.36% | -68.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -177.27% | -122.27% | -94.02% | -79.36% | -68.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -177.27% | -122.27% | -94.02% | -79.36% | -68.75% |
|
|
|||||